INTRODUCTION
Vascular access care has evolved significantly during the last decade since the National Kidney Foundation's original Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines were published in 1997. These guidelines identified both evidence-based and opinion-based recommendations to improve vascular access outcomes in the United States. Interventional nephrology has developed in parallel and is now emerging as a distinct nephrology subspecialty. Box 1 shows historical highlights within the context of the field as a whole. The continued success of interventional nephrology requires the commitment of academic training centers. At present, the program requirements for residency education in nephrology lack sufficient detail to adequately prepare trainees for interventional procedures. As a result, a graduating nephrology trainee's vascular access knowledge frequently is inadequate to provide optimal care to patients with kidney failure. As a developing subspecialty of nephrology, interventional nephrology must become an integral part of the nephrology training experience. Nephrology training programs need to become actively engaged in modifying the training to include, at a minimum, core vascular access knowledge for each trainee. These needs have been partially addressed in previous Core Curricula appearing in the American Journal of Kidney Diseases; namely, an article from Maya and Allon on vascular access (April 2008) and an article from O'Neill and Baumgarten on diagnostic ultrasonography (September 2003); both articles are freely available at www.ajkd.org.
Interventional nephrologists have a pivotal role to play, working in concert with general nephrologists, interventional radiologists, and vascular surgeons to optimize care of dialysis patients. This Core Curriculum on interventional nephrology is designed for nephrologists who wish to make interventional nephrology a major career focus. It is based on the curriculum adopted by the American Society of Diagnostic and Interventional Nephrology (ASDIN) and the training manual developed by Dr Gerald Beathard.
EPIDEMIOLOGY
Until recently, vascular access was a leading cause of hospitalization (Ͼ20%) in the end-stage renal disease population. With an increasing number of vascular access procedures being performed in outpatient settings, there has been a greater than 35% decrease in hospital admissions related to vascular access for hemodialysis patients. 2 Nephrologists are now performing an increasing number of interventions to minimize the morbidity and mortality associated with vascular access complications. 2 Appropriately trained interventional nephrologists can perform these procedures in a safe and effective manner: in 2004, Beathard and Litchfield reported that more than 14,000 procedures had been performed by interventional nephrologists, with success and complication rates of 96% and 3.5%, respectively. It cannot be emphasized enough that the key word here is primary operator, with the trainee performing the procedure with no intervention from the supervising physician. 1. Angiography: As the primary operator, the trainee must satisfactorily perform complete angiographic procedures designed to study peripheral hemodialysis vascular access in 25 patients under the supervision of a qualified interventionist. This should include both arteriovenous grafts and autogenous fistulas. 2. Angioplasty: As the primary operator, the trainee must satisfactorily perform angioplasty procedures on the hemodialysis vascular access in 25 patients under the supervision of a qualified interventionist. This should include both arteriovenous grafts and autogenous fistulas. 3. Thrombolysis/thrombectomy: As the primary operator, the trainee must satisfactorily perform thrombolysis/thrombectomy procedures on the hemodialysis vascular access in 25 patients under the supervision of a qualified interventionist. This should include both arteriovenous grafts and autogenous fistulas.
ADDITIONAL READING
4. Nontunneled short-term hemodialysis catheters: As the primary operator, the trainee must satisfactorily place nontunneled short-term hemodialysis catheters in 25 patients. This requirement may have been met as part of a trainee's primary nephrology training. In this case, appropriate documentation of experience is required. 5. Tunneled cuffed long-term hemodialysis catheters: As the primary operator, the trainee must satisfactorily place tunneled cuffed long-term hemodialysis catheters in 10 patients under the supervision of a qualified interventionist. perform the advanced procedures encountered in interventional nephrology, he or she must have first completed training in the basic procedures of interventional nephrology and possess a knowledge base sufficient for the safe, effective, and efficient application of these procedures. At a minimum, a period of didactic training is essential to address the following topics: A. Endovascular stent placement: The role of endoluminal stents has not been fully delineated in the interventional management of dialysis access. In the United States, stents are not approved by the Food and Drug Administration for use in dialysis access, and their use is justified only if there are clear indications that they will either extend the life of the access or save an otherwise failed access and avoid surgery. In addition, a stent adds considerably to the cost of the procedure and has the potential to promote the development of neointimal hyperplasia and deplete the vein that may be used for future revisions, as well as migrate into the circulation. At present, the indications for stent placement are few. 1. Indications for stent placement: a) Vein rupture: Vascular injury at the site of angioplasty may result in extravasation of contrast or a hematoma. Management depends on its effect on flow and its size. The first option would be to gently reinflate the angioplasty balloon across the site; however, if this is unsuccessful, a stent may be placed. b) Elastic lesion: An elastic lesion is one that dilates completely with the angioplasty balloon, but after dilatation still has significant (Ն50%) residual stenosis, showing elastic recoil. Due consideration should be given to surgical revison; however, if the lesion is not surgically accessible, a stent may be placed. 2. Contraindications for stent placement: a) Surgically accessible venous stenosis b) Infected access c) Undersized stent (potential for migration) d) Cannulation sites (although a covered stent may be used) e) Placement at bends and curves f) Placement at the confluence of 2 vessels 3. Stent construction and types: Selfexpanding stents commonly are used for dialysis access. They are intentionally oversized at the time of placement and continue to expand after placement. A majority of stents available are made of nitinol, a metal alloy that is elastic and has "thermal shape memory." Heating to more than a certain temperature allows the stent to regain its original shape and strength. The elasticity allows it to be introduced into the body through relatively small delivery systems. When de-ployed inside the body, it expands to its original shape as a result of the thermal effect. 4. Access patency after stent placement:
Stents may promote neointimal hyperplasia, and primary patency rates average 20% at the end of 1 year. However, with the use of adjunct devices, cumulative patency may be increased to 70% at the end of 1 year. In view of the limited patency rates and depletion of a section of the vein that eventually may be needed for a surgical revision, the authors recommend judicious use of stent placement, and angioplasty should be used as the primary treatment for all venous lesions. B. Accessory vein (fistula side-branch) obliteration: Accessory vein obliteration may be used to salvage immature arteriovenous fistulas. The decision to obliterate an accessory vein is based on its significance, evidenced by its size and the amount of flow through it. In addition, if the arteriovenous fistula augments on occlusion of the accessory vein, it may be helpful in making the diagnosis. However, any downstream lesion should be treated before obliterating an accessory vein because these can be functional and may disappear after successful resolution of downstream stenosis. There are 3 ways to obliterate accessory veins: percutaneous ligation, surgical cutdown and vein isolation, and coil placement and obliteration. 1. Percutaneous ligation: This should be attempted only if the vein is visible or palpable. The fistula should be cannulated below the most distal accessory vein, and an angiogram should be obtained. The accessory vein then should be marked on the skin surface with a sterile marker. The area over the accessory vein should be anesthesized, and a suture should be placed through the skin to encircle the vein. However, a repeated angiogram needs to be obtained to confirm obliteration of the accessory vein before tightening the suture, which may be removed after 10 days. B. Initial access: The PD catheter generally is placed on the left side. Using both conscious sedation and local lidocaine, a 5-cm incision is made 1 to 2 cm below and 2 to 3 cm lateral to the umbilicus. Using blunt dissection, the rectus sheath is exposed. Although this entry point usually avoids the epigastric artery, an ultrasound probe may be used to document its location. A 22-G needle from a micropuncture set is inserted with the needle directed toward the lower pelvis. Verification that the needle is within the peritoneal cavity is confirmed by injecting a small amount of contrast. If the needle is within the peritoneal cavity, a typical bowel pattern should be observed under fluoroscopy. The micropuncture wire then is inserted through the needle under fluoroscopic guidance to confirm its position in the lower pelvis. The needle is exchanged for a 5-Fr dilator, and a 0.035 guidewire then is advanced through the dilator into the lower pelvis. C. Catheter placement: The opening into the peritoneal cavity is enlarged by using serial dilators over the guidewire until a final 18-Fr dilator with a peel-away sheath is advanced over the wire (Cook-Medical Inc, Bloomington, IN). The PD catheter is advanced over the guidewire into its final location and the internal cuff is buried in the rectus muscle. Approximately 500 mL of dialysate is infused rapidly through the catheter, and its outflow is assessed to confirm adequate function. The urinary bag is checked and the clarity of the dialysate is noted to ensure no complications. D. Subcutaneous tunnel: A subcutaneous tunnel for the PD catheter is created to the exit. Specifically, the external cuff should be located 1 to 2 cm within the tunnel from the exit site, and the exit site, created by using a no. 11 scalpel, should allow for a tight fit around the catheter and not require sutures. The surgical incision is closed in layers. The catheter is flushed with heparinized saline after the appropriate connectors have been attached. E. Postoperative care: Postoperative care includes securely capping the catheter, covering the incision with sterile gauze and not using bio-occlusive dressings, and keeping the site dry. The catheter usually is not used until 3 to 4 weeks after implantation before full fluid exchanges of 2 to 3 L are started. During this waiting period, depending on PD unit policy, the catheter may be accessed once a week, during which small volume exchanges of 500 mL are performed. Mechanisms for the reordering of supplies must be established. Adequate storage for supplies must be provided. D. Staff: To perform interventional procedures, adequately trained dedicated staff must be provided so that the procedure can be performed safely, effectively, and efficiently. The following minimal number of staff is required: 1. Advanced Cardiac Life Support-certified nurse to monitor the patient during the procedure 2. Scrub technician to assist the operator in performing the procedure 3. Technician to manage the radiographic equipment during the procedure (certified radiology technician is recommended) E. Volume of procedures: For a training program to be successful, it should be actively performing interventional procedures on an ongoing basis. The minimum annual procedures required to attain and maintain accreditation are listed in Table 3 .
F. Procedure records: Reports of the procedures performed must be generated and placed in the patient's permanent medical record. Documentation of all procedures is a necessity. Each trainee should receive documentation of the types of procedures performed, the number of each type of procedure performed, and the outcome of the procedure. Maintaining a computerized database is strongly recommended. G. Quality assurance: An ongoing quality assurance program is an essential part of any interventional facility. The purpose of this program should be to provide for a systematic method to continuously assess and improve all aspects of health care delivery. It should be designed to improve patient care outcomes through the ongoing objective assessment of important aspects of patient care based on quality, cost, and service and the appropriate solutions of identified problems. Medical necessity, appropriateness of care, and adverse outcomes should be monitored. Practice guidelines should be developed and monitored. Outcome data should be collected and analyzed on an ongoing basis. 1. Site visit: Accreditation will require a site visit after these criteria are met, but not before 6 months after initiation of the program. 2. Accreditation interval: For the program to maintain its status with the ASDIN, it must be accredited every 3 years. The Accreditation Committee of the ASDIN will determine the process by which this is accomplished.
